The Drugs Controller General of India (DCGI) gave the approval to the Hyderabad-based pharmaceutical company on Sept 1, the statement said. The company will study the safety and tolerability of its vaccine, CORBEVAX, in this population, it added. Of these, the COVID-19 shots for adults by Bharat Biotech and Zydus Cadila have been indigenously developed. In late August, India also approved Cadila's COVID-19 vaccine, the world's first DNA shot against the virus, for emergency use in children aged 12 years and above. Biological E is also running a late-stage trial of its vaccine in adults.

Source: bd News24 September 03, 2021 09:22 UTC